Radiological evidence of inflammation related to CAA is relatively common and most cases may go undetected and untreated, a Cleveland Clinic study shows.
Read MoreNew Studies Assess Promise of Tumor Treating Fields
In an attempt to improve the dismal survival statistics for glioblastoma, investigators are evaluating the use of low-intensity electric fields to inhibit the growth of tumor cells.
Early Brain Injury After SAH: Is Ischemia Happening Faster Than We Imagined?
Recent prospective MRI studies found evidence of early ischemia in two-thirds of patients acutely after SAH. We’re now planning studies aimed at correlating platelet-leukocyte interactions with this MRI evidence of ischemia.
Brain Activity After Concussion: fMRI Studies Show a Shift in Activation and a Lasting ‘Neural Signature’
Two recent functional neuroimaging studies advance our understanding of how the brain changes with concussion, raising the prospect of one day using fMRI for disability assessment and rehab planning.
No Laughing Matter: Defining the Role of a New Agent for Pseudobulbar Affect
After making its mark as the first therapy approved for pseudobulbar affect (pathologic laughing and crying) in ALS and MS, Nuedexta is under study for additional uses in a range neurologic diseases.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Recombinant Human Bone Morphogenetic Protein-2: Friend or Foe?
There’s no arguing that rhBMP-2 forms bone. The latest research aims to learn whether its adverse effects outweigh its benefits, and in which types of spine fusion procedures the risk-benefit ratio is most favorable.
New Analysis Highlights Urgent Need for Alzheimer’s Disease Drug Development
Even with an estimated 44 million people living with Alzheimer s disease (AD), relatively few new AD drugs are in development. Additionally, the failure rate for AD drug development is 99.6 percent from the years 2002 to 2012 and the number of AD drugs has been declining since 2009. In a new analysis published today, researchers say there is an urgent need to increase the number of agents entering the AD drug development pipeline.
How Whole Brain 3-D Magnetic Resonance Spectroscopy Is Advancing Exploration of Neuropsychiatric Disorders
Insights from 2-D MRS studies have ignited a quest to study chemical changes in large volumes of brain simultaneously using 3-D PEPSI imaging. And they hint at what’s possible with MRS at 7-tesla field strength.
New Virtual Reality System Uses Multisensory Immersion to Challenge Rehab Patients While Delighting Them Too
The novel CAREN system allows safe challenging of rehab patients through scenarios in an immersive virtual environment. Early use centers on Parkinson disease and MS, but clinical and research applications may be boundless.
Robot-Assisted Stereotactic Laser Ablation Under Real Time MRI: A First Operative Technique Report in Intractable Epilepsy
Cleveland Clinic surgeons share the first known report of the combined use of three advanced operative tools for intractable focal partial epilepsy. Recovery was swift for the 19-year-old patient.
Here’s What the Future of Neuroimaging Research Looks Like
7-tesla MRI imaging is taking neuropsychiatric research into new territory with awe-inspiring resolution — and the story of what’s involved in scanner installation is pretty impressive too.